|Property||Resources - Mining|
|Resources - Oil & Gas||Technology|
|UK Commercial Property Trust||F&C Managed Portfolio Trust|
|Custodian REIT||Target Healthcare REIT|
|Blancco Technology Group||Collplant Holdings|
i-design is a specialist provider, via its propriety solution, joono, of software and marketing services for banks and ATM network owners worldwide to run both internal marketing campaigns and third-party advertising.
IdaTech develops fuel cells technologies and related applications. Through its technology, IdaTech seeks to address the growing demand for clean, convenient, dependable and scalable sources of power.
As the leader in the German market, ifa systems has an established position in the expanding international market for ophthalmology software and clinical decision support systems.
IG Design Group is one of the world's leading designers, innovators and manufacturers of gift packaging and greetings, social expression giftware, stationery and creative play products.
Imagination supplies semiconductor system-on-chip (SoC) intellectual property to chipmakers and OEMs. Its primary markets are mobile handsets, consumer electronics and automotives.
Immunovia is a Swedish company, specialised in diagnostics for oncology and autoimmune diseases. Its main product is IMMray PanCan-d, an antibody microarray based on its proprietary IMMray platform. A prospective trial in high-risk patients will start in Q416. The company expects to generate initial out-of-pocket sales in 2018.
Impax Asset Management is a leading investment manager dedicated to the environmental and cleantech sectors, with a focus on alternative energy, water and waste. As at 30 November 2009, group assets under management were £1.42bn.
Imugene is an immune oncology company developing HER-Vaxx, a proprietary HER2 +ve cancer vaccine. A Ph Ib dose study is planned in gastric cancer starting in mid-2016 with a direct Ph II follow-on study in 68 patients.
Incyte is a biopharmaceutical company focusing on developing and commercialising small molecule drugs for serious diseases. Jakafi (Jakavi) is the company's first approved drug. Other drug candidates include baricitinib (partnered with Lilly) for inflammatory diseases, INCB28060 and INCB24360 for cancer.
Infrastructure India invests in Indian infrastructure projects including electricity (hydroelectric and wind power) generation, transmission and distribution and transportation (logistics including toll roads, rail, ports and airports, transport interchanges and distribution hubs). It targets projects with substantial capital and income growth potential.
Innate is a French biotech, developing first-in-class immunotherapy drugs for cancer and inflammatory diseases by developing new monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity.
Inphi is a fabless semiconductor company providing very high-speed analog interface products for server and communications markets. It is based in Californiaâ€™s Silicon Valley.
Inspired Energy is an energy (electricity and gas) procurement and management services company.
IBT aims to achieve long-term capital growth by investing in development stage biotechnology and other life sciences companies, both quoted and unquoted, that have high growth potential. IBT invests in companies considered to have good prospects, experienced management and strong upside potential through the development and/or commercialisation of a product, device or enabling technology.
International Mining & Infrastructure Corporation (IMIC) is an AIM-listed mining company that approaches stranded West African iron ore assets from an infrastructure-provision perspective, with an initial focus on Cameroon. The company's major transaction was a takeover of Afferro in December 2013, whereby IMIC acquired control over Nkout, Ntem, Akonolinga and Ngoa iron ore projects.
International Stem Cell is an early-stage biotechnology company developing therapeutic, biomedical and cosmeceutical applications for its proprietary stem form of pluripotent stem cells – human parthenogenetic stem cells (hpSCs). Its lead candidate is a cell therapy treatment for Parkinson’s disease.
Intu Properties, formerly Capital Shopping Centres, owns and operates 16 shopping centres across the UK, with 16.6m sq ft of retail space, including 10 of the UK's top 25 centres, valued at Â£7bn.
Invesco Income Growth Trust aims to provide long-term capital growth and real growth in dividends from a portfolio yielding more than the FTSE All-share Index.
InVision provides workforce management software and online training for contact centres on a software as a service platform. It is based in Germany and is focused on European and North American opportunities as the market moves from in-house to professional solutions.
IPB Petroleum is an Australia-focused E&P with acreage in the Browse Basin (offshore NW Australia). It has a full carry on its first exploration well Pryderi-1 by CalEnergy.
IQE is the leading supplier of epitaxial compound semiconductor wafers globally. The principal applications include radio frequency semiconductors, CPV solar cells and vertical cavity lasers.
Ironwood Pharmaceuticals is a US company focused on developing and commercialising products that address gastrointestinal, CNS, and respiratory disorders, as well as pain and inflammatory conditions. Its first drug, Linzess (linaclotide) for constipation disorders, is now approved in the US.
IS Solutions is a systems integrator focused on the internet. The group offers software products, specialist projects and managed services across three key areas – portals, content/document management and analytics.
ITE Group is a leading international exhibition organiser. The group's primary markets are Russia (61% FY12 revenue), Eastern and Southern Europe (16% FY12 revenue) and Central Asia (16% FY12 revenue). The euro represents c 36% of group revenue and the Russian rouble 37%.
ITV is an advertising-funded media owner in the UK comprising broadcasting, global content and online content.
IVS is the leader in the vending machine industry in Italy and the third largest player in Europe. IVS provides for the installation, maintenance and refill of fully automatic vending machines and semi-automatic small machines and Office Coffee Service (OCS) machines.
ICAP is the world's leading voice and electronic interdealer brokers and provider of post trade risk and information services. The Group is active in the wholesale markets in interest rates, credit, commodities, FX, emerging markets, equities and equity derivatives.
iCo Therapeutics is a Canadian biotech company that in-licenses novel therapeutics. Lead candidate iCo-007, an antisense compound licensed from Isis Pharmaceuticals, is being evaluated for diabetic macular edema (DME).
IFG provides financial services, comprising a platform for retirement wealth planning and personal advisory business primarily operating in the UK. Through James Hay Partnership it is one of the largest UK platform providers.
IG Group is a world-leading provider of financial spread betting and CFDs, with operations in the UK, Europe, US, Japan and Singapore.
Ilika searches for new materials in the renewable and clean energy space. It is unique in that it has patented technology that allows it to discover new materials much faster than conventional methods.
Immune Pharmaceuticals (formerly EpiCept) is a specialty pharmaceutical company focused on the development and commercialisation of pharmaceutical products for cancer treatment and pain management.
Immunodiagnostic Systems (IDS) develops, and sells in vitro diagnostic tests for bone and cartilage. It has an automated system, iSYS. Most sales come from a manual “stored” Vitamin D test. The complex active Vitamin D test (with two hydroxyl groups) is manual but may be automated by FY12. Other tests have been developed.
ImmuPharma is a UK drug development company linked to the leading French research organisation (CNRS). The lead project, Lupuzor for lupus, has completed a Phase IIb trial and a development partner is being sought.
Inchcape is an international automotive distributor and retailer. The UK (36% of revenue) is the largest sales territory, but there are key businesses elsewhere in Europe (18%), Asia (16%) and Australasia (14%). The group also has businesses in Russia and a number of emerging markets (16%).
INDUS comprises 42 companies operating in five sectors: Construction/ Infrastructure (19% 2013 revenue); Automotive Technology (29%); Engineering (17%); Medical Engineering/Life Science (8%); and Metal/Metal Processing (27%).
Infinity Pharmaceuticals is a US biotech company focused on oncology. The company has four products in clinical development, three of which are subject to the global alliance with Mundipharma (and its US affiliate Purdue).
Inmarsat owns and operates satellites that provide mobile voice and data communications to customers around the world. Services include voice and internet connectivity as well as transmission of data to and from machines. Coverage of these services is global.
Innovation Group provides outsourcing and software to the insurance industry and related sectors. It uses a combination of software, innovative repair techniques, economies of scale and domain expertise to streamline the insurance claims cycle.
Insmed is a US pharmaceutical company focused on the development of Arikace (liposomal amikacin for inhalation) for serious lung diseases, including: Pseudomonas aeruginosa in cystic fibrosis (Phase III complete) and non-tuberculous mycobacteria (Phase II ongoing).
Intec Pharma is a drug delivery company that has developed the accordion pill, a novel gastroretentive controlled release formulation. The company is currently using this technology to develop AP-CDLD for Parkinson’s in Phase III and AP-ZP for insomnia in Phase II.
Intelligent Energy delivers clean energy solutions for the distributed energy, diesel replacement, automotive and aerial drone markets. It works with international companies to embed its fuel cell stack technology into applications across target markets.
International Personal Finance provides home credit to 2.1m customers across a number of emerging markets. It has operations in Poland (1997), Hungary (2001), Romania (2006), Czech republic (1997) and Slovakia (2001). Mexico (2003) now has 524k customers
The investment objective of Invesco Asia Trust is to provide long-term capital growth by investing in a diversified portfolio of Asian (defined primarily as China, Hong Kong, India, Malaysia, Singapore, South Korea, Taiwan, Thailand) and Australasian companies. The company aims to achieve growth in its net asset value in excess of the MSCI All Countries Asia-Pacific ex-Japan Index, measured in sterling.
Invion is an Australian healthcare company targeting inflammation. The lead drug candidates are in Phase II development targeting both asthma (INV102, repurposed nadolol) and autoimmune disorders (INV103). In addition INV104 (repurposed zafirlukast) to treat asthma attacks is in preclinical studies.
Ion Beam Applications sells proton and electron beam accelerators used in therapy and industry respectively and measuring equipment to assess radiation dose: dosimetry. Therapy systems are long-term, 2-3 year contracts to build entire facilities. There is a JV with SK Capital in Molecular Diagnostics but this is being evaluated.
Qiagen Marseille (formerly Ipsogen) specialises in developing and marketing molecular diagnostic tests for cancer (leukaemia and breast cancer).
Iridex is an ophthalmic device company focused on laser consoles, consumables and surgical instrumentation. It has developed a micropulse laser delivery system that allows laser thermal photodisruption without structural tissue damage.
Ironwood Gold is a US-listed gold exploration company with projects in Nevada, US.
Is Private Equity (ISGSY) is a listed private equity fund, which invests directly in Turkey's growing mid-cap private companies.
Is Yatirim Menkul Degerler (also known as Is Investment) offers brokerage, corporate finance, investment advisory services and portfolio management services. It also has investments in four subsidiaries whose results it consolidates.
Ithaca Energy is a Canadian independent oil and gas company with exploration, development and production assets in the UK North Sea.
IVG is a real estate and infrastructure investment company with 550 employees in 19 European locations, managing assets of â‚¬21bn. This includes â‚¬3.2bn of directly held German office buildings, â‚¬15.2bn of real estate funds for institutional and private investors and â‚¬1.1bn in oil and gas storage.